EZ EM INC
10-K, EX-27, 2000-09-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: EZ EM INC, 10-K, EX-23, 2000-09-01
Next: EZ EM INC, 10-K, EX-99, 2000-09-01



<TABLE> <S> <C>

<ARTICLE>                   5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Company's  Form  10-K  for the  fifty-three  weeks  ended  June 3,  2000  and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                1,000

<S>                                             <C>
<PERIOD-TYPE>                                   YEAR
<FISCAL-YEAR-END>                                     JUN-03-2000
<PERIOD-END>                                          JUN-03-2000
<CASH>                                                      5,583
<SECURITIES>                                                8,051
<RECEIVABLES>                                              23,109
<ALLOWANCES>                                                  853
<INVENTORY>                                                26,856
<CURRENT-ASSETS>                                           67,276
<PP&E>                                                     50,030
<DEPRECIATION>                                             28,309
<TOTAL-ASSETS>                                             99,085
<CURRENT-LIABILITIES>                                      15,842
<BONDS>                                                       453
                                           0
                                                     0
<COMMON>                                                      992
<OTHER-SE>                                                 79,042
<TOTAL-LIABILITY-AND-EQUITY>                               99,085
<SALES>                                                   112,093
<TOTAL-REVENUES>                                          112,093
<CGS>                                                      61,628
<TOTAL-COSTS>                                              61,628
<OTHER-EXPENSES>                                           41,866
<LOSS-PROVISION>                                               37
<INTEREST-EXPENSE>                                            253
<INCOME-PRETAX>                                             9,234
<INCOME-TAX>                                                3,269
<INCOME-CONTINUING>                                         5,965
<DISCONTINUED>                                                  0
<EXTRAORDINARY>                                                 0
<CHANGES>                                                       0
<NET-INCOME>                                                5,965
<EPS-BASIC>                                                   .60
<EPS-DILUTED>                                                 .58


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission